News

Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills

AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school ...

3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs

US President Trump imposed 200% tariff on pharmaceuticals affecting US drug prices and supply chain, but analysts say it may ...